Bioactive peptides are present in most soy products and eggs and have essential protective functions. Infection is a core feature of innate immunity that affects blood pressure and the glucose level, and ageing can be delayed by killing senescent cells. Food also encrypts bioactive peptides and protein sequences produced through proteolysis or food processing. Unique food protein fragments can improve human health and avoid metabolic diseases, inflammation, hypertension, obesity, and diabetes mellitus. This review focuses on drug targets and fundamental mechanisms of bioactive peptides on metabolic syndromes, namely obesity and type 2 diabetes, to provide new ideas and knowledge on the ability of bioactive peptide to control metabolic syndromes. Â© 2021 by the authors. Licensee MDPI, Basel, Switzerland.
The role of bioactive peptides in diabetes and obesity.
Shucheng Liu, College of Food Science and Technology, Guangdong Ocean University, Guangdong Provincial Key Laboratory of Aquatic Products Processing and Safety, Guangdong Province Engineering Laboratory for Marine Biological Products, Guangdong Provincial Engineering Technology Research Center of Marine Food, Key Laboratory of Advanced Processing of Aquatic Product of Guangdong Higher Education Institution, Zhanjiang 524088, China. E-mail Lsc771017@163.com
- Views Icon Views
- Share Icon Share
- Search Site
Ramachandran Chelliah, Shuai Wei, Daliri, E. B. M., Elahi, F., Su-Jung Yeon, Akanksha Tyagi, Shucheng Liu, Hasan Madar, I., Ghazala Sultan, Deog-Hwan Oh; The role of bioactive peptides in diabetes and obesity.. IFIS Food and Health Sciences Database 2022; doi:
Download citation file: